Immunogenicity and Safety of a Third Dose and Immune Persistence of BBIBP-Corv Vaccine in People With HIV Infected
Clinical trial NCT05105295 · UNKNOWN
Trial details
- NCT number
- NCT05105295
- Sponsor
- China National Biotec Group Company Limited
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-06-30
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.